Page 463 - ANUAL REPORT MOH 2017

PHARMACEUTICAL
• OFF-TAKE AGREEMENT (OTA)
The Off-Take Agreement (OTA) is one of the Government’s initiatives to help local manufacturers in
developing a vibrant pharmaceutical and medical devices industry in Malaysia. The programme is to
provide additional incentive for local manufacturing of new pharmaceutical and medical devices products
for exports and to encourage new investments. The Policy and International Relations Division acts as
a focal point in coordinating OTA application from pharmaceutical companies with Entry Point Project
(EPP) status.

For 2017, OTA contract agreement with Kotra Pharma (M) Sdn. Bhd. for products Pantoprazole 40mg
Injection and Omeprazole 40mg Injection was sealed.

• EXPORT GROWTH OF PHARMACEUTICAL PRODUCTS
This Division has been entrusted to monitor the export growth of pharmaceutical products. Target is set
based on global pharmaceutical industry growth forecasts of between 8 percent to 10 percent annually.

2017 (KPI Under Secretary, DHA)
Target 2017 : RM796,294,209.00 (8 percent growth compared to 2016)
Achieved 2017 : RM938,499,217.00 (117.86 percent)

• PROJECT TOUCH POINT CRITICAL HEALTH INTERVENTION FOR PEOPLE, MINISTRY OF
HEALTH MALAYSIA UNDER CABINET AWAY DAY 2017
The Policy and International Relations Division coordinated four (4) Touch Point projects as follows:
i. Dentures For The Elderly Project;
ii. Cataract Surgery Project;
iii. Audiometry Screening Project; and
iv. Diabetes Retinopathy Screening Project.

ORGANISING INTERNATIONAL SOURCING PROGRAM (INSP) 2017
MoH and Malaysia External Trade Development Corporation (MATRADE) jointly organised International
Sourcing Program (INSP) 2017 from 24 to 27 July 2017 at the Kuala Lumpur Convention Centre. This
program was organised in conjunction with the Association of Private Hospitals of Malaysia (APHM)
International Healthcare Conference and Exhibition 2017 (AIHCE).

The main objective of organising INSP is to boost the potential of local medical device and pharmaceutical
companies and products in international market. INSP also serves as a platform to convene international
and local companies in establishing strategic collaboration, hence assisting local companies to build
network with international companies. As such, it is prominent to note that INSP plays a vital role
in supporting the efforts to encourage the promotion and growth of exports of medical device and
pharmaceutical industry in Malaysia as a whole. The main INSP’s program is One-to-One Business
Meeting between local and international companies.

In 2017, there is an increase in participation from countries and companies, as compared to previous
years. INSP 2017 recorded participation from a total of 26 international companies from 12 countries
including India, Myanmar, Philippines, Vietnam, Chile, United Arab Emirates, Mauritius, Poland,
Kazakhstan, Cambodia, Pakistan and South Korea. About 80 local companies were in attendance in one
to one business meetings session. Throughout the event, it recorded a total of 493 business meetings.
Trade deals worth an estimated USD103.39 million for gloves, medical disposables, pharmaceuticals,
antiseptics and disinfectants were concluded and the biggest contributors were from three companies
India, Philippines and Vietnam.

462 ANNUAL REPORT 2017 MINISTRY OF HEALTH MALAYSIA